| Literature DB >> 10235108 |
A Sajadieh1, H H Storm, J F Hansen.
Abstract
The risk of cancer in users of verapamil was assessed in a long-term follow-up of 1,775 patients who were randomized to verapamil or matching placebo in the Danish Verapamil Infarction Trial-II in the years 1985 to 1987. During 10,474 patient-years, no increased risk of cancer was observed for the verapamil-treated men or women compared with the age- and sex-matched background population.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10235108 DOI： 10.1016/s0002-9149(99)00113-7
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778